Latest period
$203.00M
YoY change
-25.7%
5Y CAGR
+7.2%
Peak year (2021)
$754.00M
Latest annual
$275.00M
Stock-Based Compensation history chart for Illumina (ILMN) from 1999 to 2025
Latest: $275.00M
Stock-Based Compensation growth chart for Illumina (ILMN) from 1999 to 2025
Latest: -25.7%
Stock-Based Compensation history table for Illumina (ILMN) from 1999 to 2025
| 2025 | $275.00M | -25.7% | −$95.00M | ||
| 2024 | $370.00M | -2.6% | −$10.00M | ||
| 2023 | $380.00M | +3.8% | +$14.00M | ||
| 2022 | $366.00M | -51.5% | −$388.00M | ||
| 2021 | $754.00M | +288.7% | +$560.00M | ||
| 2020 | $194.00M | 0.0% | $0.00 | ||
| 2019 | $194.00M | +0.5% | +$1.00M | ||
| 2018 | $193.00M | +17.7% | +$29.00M | ||
| 2017 | $164.00M | +27.1% | +$34.94M | ||
| 2016 | $129.06M | -2.7% | −$3.53M | ||
| 2015 | $132.59M | -13.1% | −$19.96M | ||
| 2014 | $152.55M | +44.2% | +$46.73M | ||
| 2013 | $105.83M | +12.2% | +$11.50M | ||
| 2012 | $94.32M | +2.4% | +$2.23M | ||
| 2011 | $92.09M | +28.5% | +$20.45M | ||
| 2010 | $71.64M | +17.8% | +$10.83M | ||
| 2009 | $60.81M | +27.5% | +$13.12M | ||
| 2008 | $47.69M | +41.3% | +$13.94M | ||
| 2007 | $33.75M | +135.9% | +$19.44M | ||
| 2006 | $14.30M | +5197.8% | +$14.03M | ||
| 2005 | $270.00K | -68.0% | −$574.00K | ||
| 2004 | $844.00K | -65.6% | −$1.61M | ||
| 2003 | $2.45M | -43.7% | −$1.91M | ||
| 2002 | $4.36M | -25.5% | −$1.49M | ||
| 2001 | $5.85M | — | +$5.85M | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | — |
- 2025$275.00M-25.7%
- 2024$370.00M-2.6%
- 2023$380.00M+3.8%
- 2022$366.00M-51.5%
- 2021$754.00M+288.7%
- 2020$194.00M0.0%
- 2019$194.00M+0.5%
- 2018$193.00M+17.7%
- 2017$164.00M+27.1%
- 2016$129.06M-2.7%
- 2015$132.59M-13.1%
- 2014$152.55M+44.2%
- 2013$105.83M+12.2%
- 2012$94.32M+2.4%
- 2011$92.09M+28.5%
- 2010$71.64M+17.8%
- 2009$60.81M+27.5%
- 2008$47.69M+41.3%
- 2007$33.75M+135.9%
- 2006$14.30M+5197.8%
- 2005$270.00K-68.0%
- 2004$844.00K-65.6%
- 2003$2.45M-43.7%
- 2002$4.36M-25.5%
- 2001$5.85M—
- 2000$0.00—
- 1999$0.00—
Stock-Based Compensation values are taken from Illumina's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Illumina (ILMN)
Stock-Based Compensation for Illumina (ILMN): headline value $203.00M · YoY -25.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Illumina (ILMN) stock-based compensation totalled $275.00M – declined 25.7% year-over-year.
Illumina stock-based compensation has grown on net over the period, with a +7.2% compound annual growth rate over 2020–2025 (5 years).
2021 marks the peak stock-based compensation at $754.00M, with the historical low of $0.00 recorded in 1999.
Illumina Stock-Based Compensation by Year
Illumina Stock-Based Compensation 2025: $275.00M
In 2025, Illumina reported stock-based compensation of $275.00M, declined 25.7% below 2024.
Illumina Stock-Based Compensation 2024: $370.00M
Illumina stock-based compensation in 2024 was $370.00M, edged down 2.6% below 2023.
Illumina Stock-Based Compensation 2023: $380.00M
2023's stock-based compensation for Illumina came in at $380.00M, edged up 3.8% from 2022.
Illumina Stock-Based Compensation 2022: $366.00M
Illumina posted stock-based compensation of $366.00M in 2022, plunged 51.5% below 2021.
Illumina Stock-Based Compensation 2021: $754.00M
Illumina stock-based compensation in 2021 was $754.00M.
See more financial history for Illumina (ILMN).
Sector peers by Stock-Based Compensation
Healthcare peers of Illumina (ILMN), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Illumina (ILMN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation